Therapeutic interventions for disease progression in Huntington's disease

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2007, Pages

  Mestre, Tiago ^a   Coelho, M M ^b   Costa, J ^b   Ferreira, J ^b   Rosa, M ^b   Sampaio, C ^b  

^a HOSPITAL DE SANTA MARIA   (Portugal)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RETRACTED ARTICLE; REVIEW;

EID: 44949232145     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006455     Document Type: Review

References (6)

1. Bonelli 2004 Bonelli RM, Wenning GK, Kapfhammer HP. Huntington's disease: present treatments and future therapeutic modalities. International Clinical Psychopharmacology 2004;19 (2):51-62.
2. Higgins 2005 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. The Cochrane Library [database on CDROM]. Chichester, UK: John Wiley & Sons Ltd.
3. Kieburtz 1994 Kieburtz, K, et al.Trinucleotide repeat length and progression of illness in Huntington's disease. Journal of Medical Genetics 1994;1 (11):872-4.
4. Lanska 1995 Lanska, DJ. George Huntington and hereditary chorea. Journal of Child Neurology 1995;10 (1):46-8.
5. Ropper 2005 Ropper AH, Brown RH. Principles of Neurology, 8th ed. McGraw-Hill, 2005.
6. TH s DCR Group 1993 Group, TH.s.DCR. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosome. Cell 1993;72:971-83.